Key Trends and Insights into the Needle-Free Drug Delivery Devices Market: Growth Rate and Opportunities to 2034
Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the needle-free drug delivery devices market grown over the years?
There has been a swift increase in the market size of needle-free drug delivery devices in the past few years. Projected to grow from $16.7 billion in 2024 to $18.67 billion in 2025, it boasts a compound annual growth rate (CAGR) of 11.8%. The boost in its growth in the historic period is attributed to various factors such as heightened incidence of chronic ailments, an elevated demand for pain-free methods of drug delivery, increased geriatric population, focus on patient safety and compliance, regulatory encouragement for the development of needle-free technology, and the broadening scale of the pharmaceutical industry.
What Is the forecasted market size and growth rate for the needle-free drug delivery devices market?
Expectations are high for significant expansion in the needle-free drug delivery devices market in the forthcoming years. The market is poised to climb to $28.86 billion in 2029, advancing at a compound annual growth rate (CAGR) of 11.5%. The upswing during this forecast period can be linked to factors such as the escalating demand for pain-free medicine administration, the growing focus on patient-oriented healthcare, broadening utilization in child and elderly patient groups, the increasing incidence of chronic conditions requiring recurring injections, improvements in technology that optimize device effectiveness and user-friendliness, broader access to healthcare in developing markets, and the rise in investment in research and development aimed at innovative delivery systems. Among the dominant trends throughout the forecast period are the swelling adoption of wearable and interconnected devices, the introduction of new microfluidic technologies, an increased emphasis on child-friendly needle-free solutions, the incorporation of artificial intelligence and machine learning algorithms, and the widening application in home healthcare environments.
Get your needle-free drug delivery devices market report here!
What are the major factors driving growth in the needle-free drug delivery devices market?
The growth of the needle-free drug delivery device market is anticipated to be driven by the escalating incidence of diabetes. Diabetes, characterized by elevated blood sugar levels due to insufficient insulin production or ineffective insulin use, is a continuing health concern. Factors such as inactive lifestyle, poor eating habits, genetic factors, urbanization, and aging, along with limited healthcare access and global increase in obesity, contribute to the upsurge of diabetes. Needle-free drug delivery devices, offering an alternative to traditional insulin injections used in diabetes management, are gaining popularity. These devices employ methods such as jet injectors or transdermal patches to transport insulin through the skin sans needles, mitigating injection-associated discomfort and fear and improving comfort. Citing the National Health Service, a government department in the UK, in June 2024, it identified an extra 549,000 individuals in England at risk of developing type 2 diabetes in 2023. This increased the total of persons with non-diabetic hyperglycemia or pre-diabetes registered with a GP to 3,615,330, marking a considerable jump from 3,065,825 in 2022; a nearly 20% increase. Thus, the growing incidence of diabetes contributes to the expansion of the needle-free drug delivery device market.
What key areas define the segmentation of the global needle-free drug delivery devices Market?
The needle-free drug delivery devices market covered in this report is segmented –
1) By Device Type: Inhalers, Jet Injectors, Novel Needles, Transdermal Patches, Other Device Types
2) By Application: Pain Management, Vaccine Delivery, Pediatric Injections, Insulin Delivery, Other Applications
3) By End-User: Hospitals And Clinics, Home Healthcare
Subsegments:
1) By Inhalers: Dry Powder Inhalers (Dpi), Metered Dose Inhalers (Mdi), Nebulizers
2) By Jet Injectors: High-Pressure Jet Injectors, Spring-Powered Jet Injectors, Battery-Operated Jet Injectors
3) By Novel Needles: Micro-Needle Arrays, Nano-Needle Arrays
4) By Transdermal Patches: Microneedle Patches, Conventional Patches ( Nicotine, Hormonal, Pain Relief)
5) By Other Device Types: Oral Drug Delivery Devices, Implantable Drug Delivery Systems, Sublingual Drug Delivery Devices
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15615&type=smp
What are the top market players propelling the growth of the needle-free drug delivery devices industry?
Major companies operating in the needle-free drug delivery devices market are Pfizer Inc., Merck & Co. Inc., Bayer AG, 3M Company, Medtronic plc, Novo Nordisk AS, Becton, Dickinson and Company, Endo International plc, Insulet Corporation, Purdue Pharma L.P., Antares Pharma Inc., MannKind Corporation, Med-Jet Inc., Portal Instruments, PharmaJet, Inovio Pharmaceuticals, Inc., National Medical Products Inc., Mika Medical Co. Ltd., Medical International Technology Inc. (MTI), NanoPass Technologies Ltd., PenJet Corporation, Akra Dermojet S.A., NuGen Medical Devices Inc., Crossject SA, Injex Pharma AG
Which trends are expected to transform the needle-free drug delivery devices market?
Prominent entities in the needle-free drug delivery device industry are concentrating on advanced options, like dual chamber inhalers, with the intention of boosting the effectiveness and simplicity of administration and addressing the evolving necessities of patients and healthcare professionals. A dual-chamber inhaler is a mechanism with two sections, each capable of containing distinct medications independently. This structure encourages the blending of multiple drugs into a single inhaler, making treatment more efficient and convenient for patients. For example, Berry Global, a plastic manufacturing firm from the US, unveiled the BerryHaler in April 2024. This is a state-of-the-art dry powder inhaler (DPI) constructed to redefine patient-centric health care solutions. The dual-chamber inhaler features a dose counter for accurate medication delivery. It’s made entirely of plastic, with no metal components, and is therefore ideal for intricate inhalation procedures. This simplifies each dosage and facilitates the effective combination of various medications. In addition, it integrates advanced characteristics such as a bi-directional mouthpiece cover for user-friendliness and cleanliness, audible alerts indicating correct usage, and an inbuilt dose counter to keep tabs on medication utilization and avert dosage mishaps.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15615
What regions are dominating the needle-free drug delivery devices market growth?
North America was the largest region in the needle-free drug delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the needle-free drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Controlled Release Drug Delivery Global Market Report 2024
Drug Delivery Devices Market 2021 – By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2030
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-market
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
